e-learning
resources
Vienna 2003
Sunday 28.09.2003
Clinical aspects of community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Different factors have impact on severe pneumonia resolution and mortality after the initial treatment period
V. Dudzevicius, A. Vitkauskiene, R. Sakalauskas (Kaunas, Lithuania)
Source:
Annual Congress 2003 - Clinical aspects of community-acquired pneumonia
Session:
Clinical aspects of community-acquired pneumonia
Session type:
Thematic Poster Session
Number:
978
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Dudzevicius, A. Vitkauskiene, R. Sakalauskas (Kaunas, Lithuania). Different factors have impact on severe pneumonia resolution and mortality after the initial treatment period. Eur Respir J 2003; 22: Suppl. 45, 978
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Factors influencing initial treatment effect and outcome of pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 478s
Year: 2002
Potential causes of increased long-term mortality after pneumonia
Source: Eur Respir J 2011; 37: 1306-1307
Year: 2011
Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2011; 39: 156-162
Year: 2012
Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2012; 39: 156-162
Year: 2012
The main risk factors of the community-acquired pneumonia delayed course
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005
Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008
Risk factors for bacterial infection in exacerbated COPD requiring admission
Source: Eur Respir J 2001; 18: Suppl. 33, 153s
Year: 2001
Clinical characteristics, outcomes and factors associated with mortality in nocardia pneumonia: 10 year experience from a developing country
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Inflammatory responses predict long-term mortality risk in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 1439-1446
Year: 2011
The problem of early mortality in pneumococcal pneumonia: a study of risk factors
Source: Eur Respir J 2015; 46: 561-564
Year: 2015
Relationship between selected initial treatment of healthcare associated pneumonia with changing treatment,intensive care requirement, hospitalization period and death rate
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018
The incidence and risk factors of ventilator associated pneumonia on the mortality in patients with traumatic brain injury
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Incidence, risk factors and outcomes of nonresolving pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011
Interleukin-6 levels as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
Risk factors of treatment failure of community acquired pneumonia in patients with COPD
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept